Myocardial perfusion imaging by cardiac magnetic resonance

Journal of Nuclear Cardiology

Volumn 13, Issue 6, 2006, Pages 841-854

  Schwitter, Juerg ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; CONTRAST MEDIUM; GADODIAMIDE; GADOFOSVESET; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE POLYLYSINE; PYRUVIC ACID; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DRUG BLOOD LEVEL; DRUG METABOLISM; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; TECHNOLOGY ASSESSMENT, BIOMEDICAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33845440067     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.09.008     Document Type: Article

References (72)

1. Ladenheim M.L., Pollock B.H., Rozanski A., Berman D.S., Staniloff H.M., Forrester J.S., et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 7 (1986) 464-471
2. Iskander S., and Iskandrian A.E. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 32 (1998) 57-62
3. Beller G.A., and Zaret B.L. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 101 (2000) 1465-1478
4. Kemp H.G., Kronmal R.A., Vlietstra R.E., and Frye R.L. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 7 (1986) 479-483
5. Shaw L.J., Hachamovitch R., Berman D., Marwick T., Lauer M., Heller G., et al. The economic consequence of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 33 (1999) 661-669
6. Saeed M., Wendland M.F., Sakuma H., Geschwind J.F., Derugin N., Cavagna F.M., et al. Coronary artery stenosis: detection with contrast-enhanced MR imaging in dogs. Radiology 196 (1995) 79-84
7. Wilke N., Simm C., Zhang J., Ellermann J., Ya X., Merkle H., et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 29 (1993) 485-497
8. Schwitter J., Saeed M., Wendland M.F., Sakuma H., Bremerich J., Canet E., et al. Assessment of myocardial function and perfusion in a canine model of non-occlusive coronary artery stenosis using fast magnetic resonance imaging. J Magn Reson Imaging 9 (1998) 101-110
9. Manning W.J., Atkinson D.J., Grossman W., Paulin S., and Edelman R.R. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 18 (1991) 959-965
10. Schwitter J., Nanz D., Kneifel S., Bertschinger K., Buchi M., Knusel P.R., et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103 (2001) 2230-2235
11. Kroll K., Wilke N., Jerosch-Herold M., Wang Y., Zhang Y., Bache R.J., et al. Modeling regional myocardial flows from residue functions of an intravascular indicator. Am J Physiol 271 Pt 2 (1996) H1643-H1655
12. Schwitter J. Myocardial perfusion in ischemic heart disease. In: Higgins C.B., and de Roos A. (Eds). MRI and CT of the cardiovascular system. 2nd ed. (2005), Lippincott Williams & Wilkins, Philadelphia 198-214
13. Panting J.R., Gatehouse P.D., Yang G.Z., Grothues F., Firmin D.N., Collins P., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346 (2002) 1948-1953
14. Keijer J.T., van Rossum A.C., Wilke N., van Eenige M.J., Jerosch-Herold M., Bronzwaer J.G., et al. Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: implications for transmural assessment of myocardial perfusion. J Cardiovasc Magn Reson 2 (2000) 189-200
15. Schwitter J., Saeed M., Wendland M.F., Derugin N., Canet E., Brasch R.C., et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 30 (1997) 1086-1094
16. Hillenbrand H.B., Kim R.J., Parker M.A., Fieno D.S., and Judd R.M. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102 (2000) 1678-1683
17. Al-Saadi N., Nagel E., Gross M., Bornstedt A., Schnackenburg B., Klein C., et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101 (2000) 1379-1383
18. Muzik O., Duvernoy C., Beanlands R.S., Sawada S., Dayanikli F., Wolfe Jr. E.R., et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 31 (1998) 534-540
19. Picano E., Parodi O., Lattanzi F., Sambuceti G., Andrade M.J., Marzullo P., et al. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography. Circulation 89 (1994) 753-761
20. Miller D.D., Donohue T.J., Wolford T.L., Kern M.J., and Bergmann S.R. Assessment of blood flow distal to coronary artery stenoses. Correlations between myocardial positron emission tomography and poststenotic intracoronary Doppler flow reserve. Circulation 94 (1996) 2447-2454
21. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med 35 (1994) 693-698
22. Sambuceti G., Parodi O., Marcassa C., Neglia D., Salvadori P., Giorgetti A., et al. Alterations in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography. Am J Cardiol 72 (1993) 538-543
23. th Meeting of the International Society of Magnetic Resonance in Medicine, May 6-12, 2006, Seattle Wash. Proceedings of the ISMRM
24. Schwitter J., DeMarco T., Kneifel S., von Schulthess G.K., Jorg M.C., Arheden H., et al. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation 101 (2000) 2696-2702
25. Klem I., Heitner J.F., Shah D.J., Sketch J.M.H., Behar V., Weinsaft J., et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 47 (2006) 1630-1638
26. Matheijssen N.A., Louwerenburg H.W., van Rugge F., Arens R.P., Kauer B., de Roos A., et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med 35 (1996) 221-228
27. Lauerma K., Virtanen K.S., Sipila L.M., Hekali P., and Aronen H.J. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 96 (1997) 2859-2867
28. Cullen J.H., Horsfield M.A., Reek C.R., Cherryman G.R., Barnett D.B., and Samani N.J. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 33 (1999) 1386-1394
29. Bertschinger K.M., Nanz D., Buechi M., Luescher T.F., Marincek B., von Schulthess G.K., et al. Magnetic resonance myocardial first-pass perfusion imaging: parameter optimization for signal response and cardiac coverage. J Magn Reson Imaging 14 (2001) 556-562
30. Tsekos N., Zhang Y., Merkle H., and Wilke N. Fast anatomical imaging of the heart and assessment of myocardial perfusion with arrhythmia insensitive magnetization preparation. Magn Reson Med 34 (1995) 530-536
31. Wilke N., Jerosch-Herold M., Wank Y., Huang Y., Christensen B.V., Stillman A.E., et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first pass MR imaging. Radiology 204 (1997) 373-384
32. Elkington A.G., Gatehouse P.D., Cannell T.M., Moon J.C., Prasad S.K., Firmin D.N., et al. Comparison of hybrid echo-planar imaging and FLASH myocardial perfusion cardiovascular MR imaging. Radiology 235 (2005) 237-243
33. Giang T., Nanz D., Coulden R., Friedrich M., Graves M., Al-Saadi N., et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 25 (2004) 1657-1665
34. Wolff S., Schwitter J., Coulden R., Friedrich M., Bluemke D., Biedermann R., et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study. Circulation 110 (2004) 732-737
35. Ishida N., Sakuma H., Motoyasu M., Okinaka T., Isaka N., Nakano T., et al. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 229 (2003) 209-216
36. Schwitter J., Debatin J.F., von Schulthess G.K., and McKinnon G.C. Normal myocardial perfusion assessed with multi-shot echo-planar imaging. Magn Reson Med 37 (1997) 140-147
37. Ding S., Wolff S.D., and Epstein F.H. Improved coverage in dynamic contrast-enhanced cardiac MRI using interleaved gradient-echo EPI. Magn Reson Med 39 (1998) 514-519
38. Kellman P., Derbyshire J.A., Agyeman K.O., McVeigh E.R., and Arai A.E. Extended coverage first-pass perfusion imaging using slice-interleaved TSENSE. Magn Reson Med 51 (2004) 200-204
39. Pruessmann K.P., Weiger M., Scheidegger M.B., and Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42 (1999) 952-962
40. Tsao J, Boesiger P, Pruessmann KP. k-t BLAST and k-t SENSE: dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn Reson Med 1031;50:1031-42.
41. Schwitter J, Bauer W, van Rossum A, Lombardi M, Al-Saadi N, Ahlstrom H, et al. MR-IMPACT: comparison of myocardial perfusion imaging with single photon emission computed tomography in known or suspected coronary artery disease: a multicentre, multivendor dose finding study [abstract]. Eur Heart J. Available at: http://www.escardio.org/knowledge/congresses/CongressReports/clinical/20 05/Schwitter.htm.
42. Araoz P.A., Glockner J.F., McGee K.P., Potter D.D., Valeti V.U., Stanley D.W., et al. 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson 7 (2005) 559-564
43. Wedeking P., Sotak C.H., Telser J., Kumar K., Chang C.A., and Tweedle M.F. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. Magn Reson Imaging 10 (1992) 97-108
44. Saeed M., Wendland M., Yu K., Li H., and Higgins C. Dual effects of gadodiamide injection in depiction of the region of myocardial ischemia. J Magn Reson Imaging 3 (1993) 21-29
45. Saeed M., Wendland M.F., Masui T., and Higgins C.B. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 31 (1994) 31-39
46. Wendland M.F., Saeed M., Yu K.K., Roberts T.P., Lauerma K., Derugin N., et al. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn Reson Med 32 (1994) 319-329
47. Larsson H.B., Rosenbaum S., and Fritz-Hansen T. Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart. Magn Reson Med 46 (2001) 272-281
48. Judd R.M., Atalay M.K., Rottman G.A., and Zerhouni E.A. Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents. Magn Reson Med 33 (1995) 215-223
49. Judd R.M., Reeder S.B., and May-Newman K. Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. Magn Reson Med 41 (1999) 334-342
50. Dauber I.M., VanBenthuysen K.M., McMurtry I.F., Wheeler G.S., Lesnefsky E.J., Horwitz L.D., et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res 66 (1990) 986-998
51. Fung A.Y., Gallagher K.P., and Buda A.J. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation 76 (1987) 943-951
52. Marwick T., Willemart B., D'Hondt A.M., Baudhuin T., Wijns W., Detry J.M., et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87 (1993) 345-354
53. Weisskoff R.M., Chesler D., Boxerman J.L., and Rosen B.R. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time?. Magn Reson Med 29 (1993) 553-558
54. Kraitchman D.L., Chin B.B., Heldman A.W., Solaiyappan M., and Bluemke D.A. MRI detection of myocardial perfusion defects due to coronary artery stenosis with MS-325. J Magn Reson Imaging 15 (2002) 149-158
55. Wilke N., Kroll K., Merkle H., Wang Y., Ishibashi Y., Xu Y., et al. Regional myocardial blood volume and flow: first-pass MR imaging with polylysine-Gd-DTPA. J Magn Reson Imaging 5 (1995) 227-237
56. Bjerner T., Johansson L., Ericsson A., Wikstrom G., Hemmingsson A., and Ahlstrom H. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients. Radiology 221 (2001) 822-826
57. Goldman M., Johannesson H., Axelsson O., and Karlsson M. Hyperpolarization of 13C through order transfer from parahydrogen: a new contrast agent for MRI. Magn Reson Imaging 23 (2005) 153-157
58. Ardenkjaer-Larsen J.H., Fridlund B., Gram A., Hansson G., Hansson L., Lerche M.H., et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 100 (2003) 10158-10163
59. Johansson E., Mansson S., Wirestam R., Svensson J., Petersson J.S., Golman K., et al. Cerebral perfusion assessment by bolus tracking using hyperpolarized 13C. Magn Reson Med 51 (2004) 464-472
60. Keijer J.T., van Rossum A., van Eenige M., Karreman A.J., Hofman M.B., Valk J., et al. Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging. Am Heart J 130 (1995) 893-901
61. Klocke F.J., Simonetti O.P., Judd R.M., Kim R.J., Harris K.R., Hedjbeli S., et al. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation 104 (2001) 2412-2416
62. Knuesel P.R., Nanz D., Wyss C., Buechi M., Kaufmann P.A., von Schulthess G.K., et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 108 (2003) 1095-1100
63. Wu E., Judd R.M., Vargas J.D., Klocke F.J., Bonow R.O., and Kim R.J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 (2001) 21-28
64. Klein C., Nekolla S.G., Bengel F.M., Momose M., Sammer A., Haas F., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105 (2002) 162-167
65. Wagner A., Mahrholdt H., Holly T., and Kim R.J. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
66. Buchthal S.D., den Hollander J.A., Merz C.N., Rogers W.J., Pepine C.J., Reichek N., et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. [see comments]. N Engl J Med 342 (2000) 829-835
67. Isbell D.C., Berr S.S., Toledano A.Y., Epstein F.H., Meyer C.H., Rogers W.J., et al. Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol 47 (2006) 2289-2295
68. Heart disease and stroke statistics-2006 update (2006), American Heart Association, Dallas
69. Fraser A.G., Buser P.T., Bax J.J., Dassen W.R., Nihoyannopoulos P., Schwitter J., et al. The future of cardiovascular imaging and non-invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine and the Association for European Paediatric Cardiology. Eur J Nucl Med Mol Imaging 33 (2006) 955-959
70. Schwitter J. Future strategies in the management of coronary artery disease. Future Cardiol 2 (2006) 555-565
71. Schwitter J., Oelhafen M., Wyss B.M., Kozerke S., Amann-Vesti B., Luscher T.F., et al. 2D-Spatially-selective real-time magnetic resonance imaging for the assessment of microvascular function and its relation to the cardiovascular risk profile. J Cardiovasc Magn Reson 8 (2006) 759-769
72. Topol E., McCarthy J., Gabriel S., Moliterno D., Rogers W., Newby L., et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104 (2001) 2641-2644